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Abstract
Background: Moringa stenopetala has been used in traditional health systems to treat diabetes mellitus. The aim of
this study was to investigate the antidiabetic activity of aqueous ethanol and n-butanol fraction of Moringa
stenopetala leaves in streptozotocin (STZ) induced diabetic rats.
Methods: The aqueous ethanol extract and n-butanol fraction of Moringa stenopetala leaves hydroalcoholic
(500 mg/kg body weight) and metformin (150 mg/kg body weight) were administered to diabetic rats. Blood
glucose, lipid profiles, liver and kidney function were examined after 14 days of experiment. Histopathological
profile of the pancreas was also observed in diabetic rats at the end of study. An oral sucrose challenge test was
also carried out to assess the post prandial effect of the extract.
Results: Oral administration of the aqueous ethanol and n-butanol extracts of Moringa stenopetala leaves
(500 mg/kg body weight) and metformin (150 mg/kg) significantly reduced blood glucose level (P < 0.05),
improved serum lipid profiles, liver enzymes and kidney functions in diabetic rats after 14 days. The extracts
also improved damage of islet of Langerhan’s in diabetic rats. The plant material reduced the post-prandial
glucose level (P < 0.001) at the dose of 750 mg/kg.
Conclusion: These findings revealed that both the aqueous ethanol and n-butanol extracts of Moringa
stenopetala leaves possess antihyperglycemic and antihyperlipidemic properties, and alleviate STZ-induced
pancreatic damage in diabetic rats. The beneficial effects of plant material in inhibition of diabetes-induced
complications are being investigated.
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Background
Worldwide, the number of people with diabetes and
pre-diabetes is exponentially increasing mainly due to
aging, urbanization, unhealthy eating habits, increasing
prevalence of obesity and lack of physical activity [1].
Diabetes mellitus is a leading cause of morbidity and
mortality worldwide, with an estimated 382 million
adults being affected and 5.1 million people killed in
2013. The prevalence is expected to be 592 million in
2035, with the greatest increases expected in low- and
middle-income developing countries of the African,
Asian, and South American regions. At present, 80 % of
the world’s populations with diabetes live in low- and
middle income countries [2]. Diabetes is also associated
with a host of life threatening and potentially disabling
macro- and micro-vascular complications [3]. Hence,
there is a much larger burden in the form of loss of
productivity as a result of restricted daily activity which
results in high economic costs. Within the increasing
interest to improve a quality and healthy life, herbal medi-
cines with blood glucose lowering effects have been used
for alternative treatment of type 2 diabetes mellitus.
Moringa stenopetala (Baker f ) Cufodontis belongs to
family Moringaceae is commonly grown in Southern parts
of Ethiopia [4]. The leaves of Moringa stenopetala are
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cooked and eaten as vegetables and the leaves and roots
are used to treat malaria, diabetes, asthma, repelled pla-
centa, hypertension and gastrointestinal problems [5, 6]. It
has been reported that Moringa stenopetala leaves and
roots showed antitrypanosomal activity [7]. The antispas-
modic effects of the leaves on smooth muscle tissues and
antibiotic properties of the seeds [5, 8] have also been re-
ported. Hypoglycemic activity has been demonstrated in
the crude aqueous extract of the leaves in normal mice
[9]. The crude aqueous/ethanol extract and fractions of
the leaves of Moringa stenopetala have been reported to
have both hypoglycemic and antihyperglycemic effects
[10, 11]. Moreover, chronic administration of the n-
butanol fraction of ethanol extract of Moringa stenopetala
leaves in alloxan-induced diabetic mice showed antihyper-
glycemic and antihyperlipedimic effects with wide margins
of safety, indicating its potential for long term manage-
ment of diabetes and dysilipidemia through enzyme inhib-
ition mechanisms [12–14]. The aim of the present study
was to investigate the pancreatoprotective effect of the
aqueous ethanol and n-butanol fraction of Moringa steno-
petala leaves on streptozotocin (STZ)-induced diabetic




Streptozotocin was purchased from (Sigma Aldrich,
Germany), Metformin was purchased from (Sanofi
winthrop industrie, France), SensoCard glucometer
and strip was purchased from(77 Electronike Kft,
Hungary). All others chemicals used were of analytical
grade.
Collections and preparation of plant materials
The leaves of Moringa stenopetala were collected from
Gamo Gofa Zone, South Nation’s Nationalities Peoples
Region, and 520 kilometers south of Addis Ababa. After
collection, the plant was identified and authenticated by a
taxonomist, and deposited in the herbarium of Ethiopian
Public Health Institute (EPHI) with a voucher number
AL-001. It was then dried under shade and crushed to
powder for extraction.
Preparation of plant material extract
The powdered leaves (1.2 Kg) were extracted by percola-
tion using 70 %( v/v) ethanol, and the mixture was then
filtered using Whatmann filter paper no. 1. The extract
was dried by evaporation using rotary vaporizers under
reduced pressure at a temperature of 40-45 °C. The resi-
due filtrate obtained was then dried by steam bath at
40 °C and kept in a refrigerator at 8 °C for experimental
usage. The yield of the aqueous ethanol extract was
20.1 % in weight by weight (w/w).
Solvent fractionation of the total ethanol extract
The procedure for solvent-solvent separation was adopted
from Ranjan [15] with minor modifications. Ten percent
(w/v) of ethanol extract of the plant was prepared with
mild hot distilled water. The dissolved aqueous ethanol
extract was separated in a separatory funnel with 50 ml of
n-hexane (3 times), and followed by 50 ml of dichloro-
methane extraction (3 times) and 50 ml of n-butanol
extraction (3 times) successively until the extracting solv-
ent became colorless. After completing the separation
process, the solvents were removed by a rotary evaporator.
The separated n-butanol separation were dried by steam
bath at 40 °C and kept in the refrigerator for the experi-
ments. The percentage yield of n- butanol was 7.8 (w/w).
Animals
The Swiss albino rats weighing 180-250 g were obtained
from the animal department of Ethiopian Public Health
Institute/EPHI/. They were kept under standard condi-
tions (at a temperature of 22 ± 2 °C, and with 12 hr light/
12 hr dark cycle) and provided with free access to
standard pellet laboratory diet and water ad libitum. The
experimental protocol was approved by the Institutional
review board (IRB) of Addis Ababa University, School of
Medicine with protocol number 001/13/pharma.
Induction of experimental diabetes
Six rats were randomly selected as normal controls. Dia-
betic rats were induced by streptozotocin (STZ) 40 mg/kg
body weight, intraperitonially (IP). STZ was dissolved in cit-
rate buffer solution (0.01 M, pH = 4.5). All the animals had
free access to water and pellet diet after thirty minutes of
administration. Five days thereafter the fasting blood glu-
cose levels of rats were determined using glucose oxidase
method with glucose analyzer. A blood glucose level greater
than 126 mg/dl was considered to be diabetes mellitus
(DM). Streptozotocin induced diabetic rats were selected
and divided in four groups; negative control, positive con-
trol, and test groups.
Sucrose tolerance test
The normal mice were divided into five groups and each
group contained six animals. The control group was
fed with distilled water. Other groups were fed orally
with three different doses of aqueous ethanol extract of
Moringa stenopetala leaves (250, 500 and 750 mg/kg). For
the last group, acarbose (3 mg/kg) was used as a positive
control. All treatments were administered to the mice
5 min before loading sucrose (3 g/kg). Blood samples were
collected from a tail vein at 0, 30, 60, 90 and 180 min. The
blood glucose levels were determined by glucose oxidase
method.
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Study on effect of aqueous ethanol extract and n-butanol
fraction on blood glucose levels
Diabetic rats were administered with 500 mg/kg body
weight of ethanol extract and butanol fraction daily for
14 days via oral gavage. The diabetic and normal rats
were given 10 ml/kg of body weight of normal saline
via oral gavage and positive control rats were given
150 mg/kg of metformin via oral gavage. On days 0, 7,
and 14 the blood samples were collected from tail vein
following overnight fasting and blood glucose levels were
measured. Body weight of each rat was determined at the
same time.
Assay of serum lipid level, hepatic enzymes and renal
function tests
On day 15, the rats were fasted overnight, blood samples
were collected in a sterile tube by cardiac puncture under
ether anesthesia and left to stand at room temperature for
2 h, then centrifuged at 1500 × g for 15 min at 4 °C. The
supernatant was immediately separated from the pellet to
prepare serum samples in order to determine the level of
triglyceride (TG), total cholesterol (TC), high density lipo-
protein (HDL), aspretate aminotransferase (AST), alanine
aminotransferase (ALT), alkaline phosphatase (ALP),
gamma gluthathione transferase (GGT), bilirubin total
(BLT), albumin, urea and creatinine using automated
chemistry analyzer (humostar 80, Germany).
Histological sample preparation
After sacrifice, the body of pancreas was dissected, col-
lected and fixed in 10 % neutral buffered formalin. The
samples were processed in graded series of alcohol
and embedded in paraffin wax, sectioned at 5 μm and
stained with hematoxylin and eosin for histological
examination.
Statistical analysis
All the values of body weight, fasting blood sugar and
serum biochemical parameters were expressed as mean ±
standard error of mean (SEM). The values were analyzed
by one-way analysis of variance (ANOVA) followed by the
Tukey’s post hoc test. The level of statistical significance
was set at P < 0.05. Analysis was performed using SPSS
software package Version 20.0.
Results
Effect of Moringa stenopetala leaf extract on postprandial
glycemia in non-diabetic mice
A single oral administration of Moringa stenopetala ex-
tract was given to non-diabetic rats to confirm its anti-
hyperglycemic activity by oral sucrose tolerance test.
The results showed that blood glucose level reached the
peak at 30 min after sucrose administration in all groups
(Table 1). In addition, the extract at a dose of 250 mg/kg,
500 mg/kg and 750 mg/kg significantly reduced a raised
blood glucose.The positive control, acarbose, significantly
reduced blood glucose after 30, 60 and 120 min of admin-
istration relative to non-treated control rats (Table 1).
Effects of Moringa stenopetala leaf extract on blood
glucose level in normal and diabetic rats
Blood glucose levels were measured once weekly in
diabetic and normal rats given Moringa stenopetala
extract after the induction of diabetes. The results are
summarized in Table 2. Before induction of diabetes,
there was no significant difference in blood glucose
levels between diabetic and non diabetic control
groups (p > 0.05). After induction, diabetic rats
showed significant differences in blood glucose levels
compared to normal rats (p < 0.05). The groups
treated with the aqueous ethanol extract and n-
butanol fraction of Moringa stenopetala leaves showed
significant reduction of blood glucose level on day 7
and 14 after administration. In addition, the lowering
blood glucose level in diabetic rats was also observed
throughout the 14 days of study when metformin was
administered.
Effect of Moringa stenopetala leaves extract on body
weight
The body weight of diabetic and normal rats given Mor-
inga stenopetala extract after the induction of diabetes
Table 1 Sucrose challenge test of hydroalcoholic extract of Moringa stenopetala in mice
Blood glucose(mg/dl) level in different time intervals (minutes)
Groups 0 30 60 120 180
Control 203.2±1.75 301.5±0.79 274.2±1.01 243.1±1.11 195.6±0.53
250 mg/kg MS extract 192.3±1.12 253.3±0.98* 226.2±0.78* 195.6±0.67* 152.3±0.78*
500 mg/kg MS extract 189.3±1.23 249.3±0.91* 233.2±1.13* 189.3±0.57** 140.8±0.45**
750 mg/kg MS extract 193.8±1.79 255.3±2.11* 226.1±1.10* 182.8±0.58** 133.4±0.23***
3 mg/kg Acrabose 192.8±0.74 223.6±1.71*** 171.0±0.79*** 155.6±1.33*** 124.8±0.37***
Results are expressed in Mean ± S.E.M, n = 6
*when p < 0.05
**when p < 0.01
***when p < 0.001 verses control
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was measured in the same rats as in the previous result
(Table 3). There were no significant differences in the
initial body weights among the groups (p > 0.05). After
the induction of diabetes, differences in body weight of
normal and diabetic rats were observed (p < 0.01). Both
the extract and fraction of Moringa stenopetala leaves
improved the weight gain compared with the diabetic
control rats. By the end of the experiment, the body
weight of the normal control group was significantly in-
creased (p < 0.001). In contrast, the rats in the diabetic
control group had slightly increased body weight during
the experimental period (p < 0.05).
Effect of the aqueous ethanol extract and n-butanol
fraction of Moringa stenopetala leaves on lipid profiles
After the induction of diabetes and subsequent treatment
with either the aqueous ethanol extract, the n-butanol
fraction or metformin, there was a significant increase of
serum total cholesterol, triglycerides, and significant de-
crease in HDL cholesterol in diabetic rats when compared
to normal rats. The results showed that administration
of aqueous ethanol extract and butanol fraction sig-
nificantly decreased (P < 0.05) the levels of cholesterol
and triglycerides (Table 4). HDL cholesterol level was
also improved in diabetic rats after 14 days treatment
(Table 4). In addition, metformin also improved the
lipid profiles in diabetic rats.
Effects of the aqueous ethanol extract and n-butanol
fraction of Moringa stenopetala leaves on liver and kidney
functions
The effects of Moringa stenopetala leaves on liver func-
tions are shown in Table 5. The levels of ALT, AST, ALP,
GGT and bilirubin were significantly elevated in diabetic
rats. The rats treated with Moringa stenopetala extrac-
tions showed significant (P < 0.05) reduction in the ele-
vated levels of liver enzymes (transaminase) and
bilirubin as shown in Table 5. Diabetic rates showed a
significant reduction in total protein levels whereas rats
treated with the extraction of Moringa stenopetala leaves
showed significantly increased levels (P < 0.05). The level
of creatinine and urea were elevated in diabetic rats as
compared with the normal rats (Table 6). Rats adminis-
tered Moringa stenopetala extracts showed reduced
levels of creatinine and urea compared to untreated dia-
betic rats (p < 0.05, Table 6). For the n-butanol fraction,
the level of creatinine was not significantly different to
that of non-diabetic rats (p > 0.05, Table 6). The results
demonstrated that Moringa stenopetala reduced enzyme
levels compared with diabetic control groups (Table 5).
Effects of aqueous ethanol extract and its butanol
fraction of Moringa stenopetala leaves on histopathology
of pancreas
The structure of the pancreas of the normal control and
diabetic rats are shown in Fig. 1. The pancreas of normal
Table 2 Effects of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves on blood glucose level in diabetic rats
Fasting blood glucose level (mg/dl)
Treatment Groups Before Induction Day 0 Day 7 Day 14
Normal control 114.00±2.11 109.67±3.39a 104.67±2.79a 104.00±3.45a
Diabetic Control 115.10±1.75 145.17±1.05b 140.50±2.29b 136.10±2.52b
DC + 500 mg/Kg ethanol extract of MS 111.67±1.19 141.56±1.50b 123.83±1.99ab 120.33±2.23ab
DC + 500 mg/Kg butanol fraction of MS 115.17±2.15 141.56±1.45b 129.67±2.40ab 123.00±1.94ab
DC + I50 mg/Kg Metformin 112.33±2.09 142.17±1.92b 124.67±2.81ab 117.83±3.05ab
Results are expressed in Mean ± S.E.M, n = 6
awhen p < 0.05 verses Diabetic control
bwhen p < 0.05 verses normal control
Table 3 Effects of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves on body weight in diabetic rats
Body weight change during treatment (g)
Treatment Groups Before Induction Day 0 Day 7 Day 14
Normal Control 221.60±5.43 262.43±4.95a 273.63±2.60a 280.83±2.08a
Diabetic Contro/DC/ 211.03±3.46b 230.68±2.73b 229.58±6.11b 231.33±5.66b
DC + 500 mg/Kg ethanol extract of MS 212.52±2.96 233.65±4.21b 244.08±2.42b 250.57±2.43ab
DC + 500 mg/Kg butanol fraction of MS 212.70±3.12 230.03±2.87b 241.50±3.78b 249.67±5.55b
DC + I50 mg/Kg Metformin 220.32±5.41 236.67±6.04b 248.67±5.67b 249.50±6.31b
Results are expressed in Mean ± S.E.M, n = 6
awhen p < 0.05 verses Diabetic control
bwhen p < 0.05 verses normal control
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control rats showed normal islets, whereas that of diabetic
rats showed hyperplasia of beta-cells and congestion of
pancreatic parenchymal cells. Administration of the aque-
ous ethanol extract and n-butanol fraction of Moringa
stenopetala leaves as well as metformin treatment in-
creased the number of islets when compared to that of
diabetic animals. The size of islets of Langerhans in the
groups treated with aqueous ethanol and metformin was
slightly reduced as compared to the normal control rats,
however the group treated with n-butanol extraction
shows islets of a similar size to that of the control group.
Discussion
Diabetes mellitus is a metabolic disorder that usually af-
fects carbohydrate, fat, and protein metabolism, followed
by multiorgan dysfunctionin the later period, and hyper-
lipidemia associated with hyperglycemia [16]. Effective
novel compounds with pan-target antidiabetic activity and
proven long-term safety should be targeted in a clinical
setting for patients with coexisting relevant lipid and glu-
cose metabolic disorders. These discoveries pave the way
for the development of drugs for treating chronic multi-
genic metabolic and cardiovascular diseases, for which
therapy is presently insufficient or nonexistent [17, 18].
This is the first study to investigate the effect of aqueous
ethanol and n-butanol fractions of Moringa stenopetala
leaves on the regenerative behavior of pancreatic islets of
Langerhans after streptozotocin induced damage of the
pancreas and on biochemical effect after such treatment.
Streptozotocin (STZ) administration generally causes
destruction of β-cells after three days in rats [19]. Pancre-
atic β -cells are particularly sensitive to damage by nitric
oxide and free radicals because of the low levels of free
radical scavenging enzymes in the tissue. The results of
the present study indicate that the extracts of Moringa
stenopetala produced regeneration/proliferation of the
pancreaticβ-cells possibly due to prevention of free radical
formation induced by STZ. Since pancreas contains stable
(quiescent) β -cells which have regenerative capacity,
after damage the surviving cells proliferate by replication
to supplicate the lost cells [20]. Regenerative pancreatic
β-cells can be formed by neogenesis or by replication of
the preexisting differentiated cells; since other medicinal
plants have shown β-cell regenerative potential, it is pos-
sible that the extracts of Moringa stenopetala were also re-
sponsible for the proliferation of β-cells and the recovery
of normal pancreatic morphology as shown in Fig. 1.
Hence this implies that extracts of Moringa stenopetala
were also responsible for the proliferation of β -cells as
there are already reports showing extracts of other medi-
cinal plants which have a β -cell regenerative potential
[21]. This medicinal plant material has also shown neovas-
cularization activity in the pancreatic islets of Langerhans
and improved stromal fibrosis of pancreatic cells in histo-
pathological investigations.
The presence of phytochemicals in plant products of-
fers a great potential for balancing metabolic distur-
bances. Several phytomolecules, including flavonoids, total
phenolic compounds, alkaloids, glycosides, saponins, glyco-
lipids, dietary fibres, polysaccharides, peptidoglycans, carbo-
hydrates, amino acids and others obtained from various
plant sources, have been reported as potent hypoglycemic
and antihyperglycemic agents. Flavonoids are a heteroge-
neous group of ubiquitous plant polyphenols, which exhibit
Table 4 Effects of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves on lipid profiles in diabetic rats
Groups TC (mg/dL) TG (mg/dL) HDL-C (mg/dL) LDL-C(mg dL}
Normal control 84.0±1.7 81.5±1.7 29.3±1.8 43.76±2.7
Diabetic control/DC 189.5±2.3a 158.50±3.1a 19.8±0.2a 141.63±2.1a
DC + 500 mg/Kg ethanol extract of MS 127.5±1.1ab 93.25±3.7ab 25.54±1.4ab 83.11±1.3ab
DC + 500 mg/Kg butanol fraction of MS 97.2±1.5b 75.00±1.1b 28.67±1.5b 51.50±2.6b
DC + 150 mg/Kg Metformin 81.7±2.9b 64.67±1.5b 34.5±1.9ab 38.03±0.5b
The results are expressed Mean ± S.E.M (n = 6)
ap < 0.05 compared with normal control values
bp < 0.05 compared with diabetic control
Table 5 Effects of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves on liver function in diabetic rats
Groups ALT (U/L) AST (U/L) ALP (U/L) BLT(mg/dl) GGT (U/L)
Normal control 32.0±2.2 57.8±2.35 53.01±0.8 0.13±0.01 3.55±0.26
Diabetic control/DC 73.0±1.7a 92.4±1.7a 85.66±1.24a 0.11 ±0.01 4.75±0.6
DC + 500 mg/Kg ethanol extract of MS 53.2±1,88ab 79.3±2.2ab 81.34±1.5ab 0.16±0.03 3.92±0.29
DC + 500 mg/Kg butanol fraction of MS 49.2±1.9ab 73.0±1.4ab 72.00±2.5ab 0.12± 0.04 3.67±0.27
DC + 150 mg/Kg Metformin 41.7±2.6ab 68.5±0.5b 61.23±1.4ab 0.10±0.01 3.82±0.37
The results are expressed Mean ± S.E.M (n = 6)
ap < 0.05 compared with normal control values
bp < 0.05 compared with diabetic control
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Table 6 Effect of Moringa stenopetala leaves extract and its butanol fraction on urea, creatinine, and total albumin STZ induced
diabetic rats
Groups Urea (mg/dL) Qreatdnme (mg/dL) Total albumin (mg/dL.)
Normal control 40.2±1.6 0.85±0.13 6.1±0.12
Diabetic control/DC 79.0±1.5a 1.87±0.18a 4.57±0.11a
DC+500 mg/Kg ethanol extract of MS 56.5±1.8ab 1.35±0.23ab 5.23±0.13b
DC + 500 mg/Kg butanol fraction of MS 53.15±1.12ab 1.23±0.3b 5.81±0.13b
DC +150 mg/Kg Metformin 50.12±1.5ab 1.15±0.2b 5.79±0.11b
The results are expressed Mean ± S.E.M (n = 6)
ap < 0.05 compared with normal control values
bp < 0.05 compared with diabetic control
Fig. 1 Histopathology of pancreas after administration of Moringa stenopetala in diabetic rats. a, x25: Pancreas of DC animal showing severe
congestion of pancreatic parenchymal cells, infiltration of inflammatory cells and hyperplasia of islets cell. b, x25: Pancreas of diabetic animal
treated with ethanol extract showing mild hyperplasia of islets cell and congestion of parenchymal cells. c, x25: Pancreas of diabetic animal
treated with butanol fraction showing mild hyperplasia of islets cell and congestion of parenchymal cells. d, x25: Pancreas of NC animal showing
normal histology. e, x25: Pancreas of diabetic animal treated with metformin showing reduced size of islets and devoid of fibrosis and necrosis
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a variety of pharmacological activities, including the anti-
atherogenic as well as antihyperglycemic effects, lipoprotein
oxidation, blood platelet aggregation and vascular reactivity
[22, 23]. A high content of phytochemicals, especially
total polyphenolic compounds and total flavonoids,
may contribute to the pleiotropic effects of Moringa
stenopetala leaves that support the use of the plant for
different metabolic disorders in the local community
[14]. A high content of total phenolic compounds and
flavonoids may have a significant role in regulating
metabolic disturbances which are highly related to dia-
betes mellitus and its complications due to its protect-
ive effect on the pancreas and other essential organs.
The most common lipid abnormalities in diabetes are
hypertriglyceridemia and hypercholesterolemia [24]. Re-
peated administration of Moringa stenopetala leaves ex-
tract and fraction for 14 days significantly decreased
hypertriglyceridemia and hypercholesterolemia. The ob-
served antihypelipidemic effect may be due to decreased
cholesterogenesis and fatty acid synthesis through inhib-
ition of pancreatic cholesterol esterase and pancreatic
lipase inhibition effect, respectively [25, 26]. The HDL
cholesterol level was significantly improved by Moringa
stenopetala leaf extract treatment. In our previous reports
we have shown that this plant material had inhibitory
effects on pancreatic cholesterol esterase and pancreatic
lipase [14] which may contribute to antihyperlipidemic ac-
tivities in animal models.
Enzymes indicating liver damage, such as AST, GGT,
ALT and ALP level increased in diabetic rats. The ele-
vated serum level of these enzymes was significantly re-
duced by Moringa stenopetala treatment. There is
evidence that the diabetic complications such as in-
creased gluconeogenesis and ketogenesis may be due to
elevated enzymes [27]. The restoration of transaminases
to their normal levels after treatment indicates revival of
insulin secretion and regenerative activities of islets of
Langerhans cells of pancreas after administration of the
plant material. Moringa stenopetala also improved renal
functions in diabetic rats by reducing serum urea and
creatinine levels. Therefore, our results demonstrate that
Moringa stenopetala is able to normalize vital organs
function in rats.
Streptozotocin has been shown to induce free radical
production and cause tissue injury. Previous studies on
histopathological investigation of organs such as liver and
kidney have shown that Moringa stenopetala was non-
toxic [28]. The pancreas is especially susceptible to the
action of streptozotocin induced free radical damage.
Moringa stenopetala leaves are rich in total polyphenolic
compounds and flavonoid and have an in vitro antioxidant
effect [13, 14]. This antioxidant activity of the plant
may protect the organ from free radicals. Various studies
have shown that diabetes is associated with increasing
formation of free radicals and decreasing antioxidant po-
tential [29]. The effect of plant material as renoprotective,
hepatoprotective and pancreatoprotective parameters may
be highly associated with its antioxidant activity.
Conclusion
These findings demonstrated that aqueous extract of
Moringa stenopetala leaves and its butanol fraction pos-
sess antihyperglycemicand antihyperlipidemic properties,
and alleviates streptozotocin induced pancreatic damage.
Thus plant material of Moringa stenopetala could be
used for prevention/treatment of hyperglycemia and
hyperlipidemia. The beneficial effects of plant material
in inhibition of diabetes induced complications such as
protein glycation are being investigated. Further studies
are warranted to investigate how the plant material
normalize blood glucose and lipid levels, and whether
insulin secretion or sensitization occur up on adminis-
tration of Moringa stenopetala leaves extract.
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